Operating Lease, Right-of-Use Asset in USD of IMMUNIC, INC. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Immunic, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2025.
  • Immunic, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $791K, a 9.91% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

IMMUNIC, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $791K -$87K -9.91% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $975K +$47K +5.07% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $968K -$130K -11.8% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $991K -$308K -23.7% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 $878K -$534K -37.8% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $928K -$927K -50% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $1.1M -$861K -44% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $1.3M -$253K -16.3% 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $1.41M +$149K +11.8% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $1.86M +$1.11M +149% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $1.96M +$1.09M +124% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $1.55M +$604K +63.7% 31 Dec 2022 10-K 22 Feb 2024
Q3 2022 $1.26M +$209K +19.8% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $745K -$420K -36.1% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $874K -$368K -29.6% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $948K +$47K +5.22% 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 $1.05M +$114K +12.1% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $1.17M +$169K +17% 30 Jun 2021 10-Q 06 Aug 2021
Q1 2021 $1.24M +$638K +106% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $901K +$268K +42.3% 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 $940K +$869K +1224% 30 Sep 2020 10-Q 06 Nov 2020
Q2 2020 $996K +$928K +1365% 30 Jun 2020 10-Q/A 03 Aug 2020
Q1 2020 $604K +$592K +4933% 31 Mar 2020 10-Q 08 May 2020
Q4 2019 $633K 31 Dec 2019 10-K 26 Feb 2021
Q3 2019 $71K 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $68K 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $12K 31 Mar 2019 10-Q 10 Apr 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.